According to a new report, published by KBV research, The Global Large And Small-scale Bioprocessing Market size is expected to reach $159.6 billion by 2030, rising at a market growth of 14.2% CAGR during the forecast period.
The In-house segment is generating the highest revenue in the Global Large And Small-scale Bioprocessing Market by Mode in 2022; thereby, achieving a market value of $98.0 billion by 2030. Large pharmaceutical and biotech firms often invest in large-scale, in-house bioprocessing facilities to expand their production capacity. This results in higher production volumes, meeting the growing demand for biopharmaceuticals. Companies with in-house bioprocessing capabilities can continuously innovate and optimize their production processes, improving efficiency, reducing costs, and enhancing product quality.
The Small-Scale segment is experiencing a CAGR of 15.7% during (2023 - 2030). Small-scale bioprocessing is valuable for conducting research, feasibility studies, and prototyping new biopharmaceutical products or production methods. It allows for quick and cost-effective testing of concepts. Some biopharmaceuticals or bioproducts require specialized or customized production processes. Small-scale bioprocessing is well-suited for such cases, allowing flexibility and adaptation to unique requirements.
The Multi Use segment is registering maximum revenue in the Global Large And Small-scale Bioprocessing Market by Use Type in 2022; thereby, achieving a market value of $91.7 billion by 2030. Multi-use facilities and equipment are adaptable and can be quickly reconfigured for different production needs. This flexibility allows companies to respond to changes in market demand and adapt to evolving product pipelines. Multi-use facilities can facilitate faster turnaround times between different production runs, as there is no need to construct or commission new equipment for each product.
The Speciality Industrial Chemicals segment is exhibiting a CAGR of 14.5% during (2023 - 2030). Specialty buffer solutions are used to maintain the pH of bioreactor cultures within a narrow and optimal range. This is essential for the growth of cells and the production of biopharmaceuticals. Specialized growth factors, amino acids, vitamins, and other media supplements are added to cell culture media to enhance cell growth and productivity. Specialty chemicals such as surfactants, lipids, and cytokines are added to cell cultures to improve cell viability, productivity, and product quality.
The Downstream Processing segment is capturing maximum revenue in the Global Large And Small-scale Bioprocessing Market by Workflow in 2022; thereby, achieving a market value of $91.3 billion by 2030. Downstream processing is integral to the large-scale production of biopharmaceuticals, including monoclonal antibodies, vaccines, recombinant proteins, and other biologics. It ensures the purification of the therapeutic product from the complex mixture of fermentation or cell culture media.
The Cell Culture Products segment would experience a CAGR of 13.9% during (2023 - 2030). Cell culture products are highly scalable, making them suitable for large-scale bioprocessing. Bioreactors and fermentation vessels can accommodate large volumes of cell culture media, enabling the production of significant quantities of biopharmaceuticals and other bioproducts to meet global demand. Standardized cell culture products, such as cell culture media, feeds, and supplements, ensure consistent cell growth and product yield across multiple batches.
The North America region dominated the Global Large And Small-scale Bioprocessing Market by Region in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $54.9 billion by 2030. The Europe region is anticipated to grow a CAGR of 13.8% during (2023 - 2030). Additionally, The Asia Pacific region would witness a CAGR of 15% during (2023 - 2030).
Full Report: https://www.kbvresearch.com/large-and-small-scale-bioprocessing-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country-wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Merck KGaA, Thermo Fisher Scientific, Inc., GE healthcare, Corning Incorporated, Sartorius AG, Lonza Group AG (Capsugel), Meissner Filtration Products, Inc., Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd., and Eppendorf SE.
By Scale
By Use Type
By Mode
By Application
By Workflow
By Product
By Geography
Companies Profiled
Unique Offerings 
